rxstat › Shortages › Hydrochlorothiazide Lisinopril
Hydrochlorothiazide Lisinopril shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Hydrochlorothiazide Lisinopril products are in shortage in Canada (3 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Sep 2, 2023
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageZESTORETIC
25MG
20MG · TABLET · SEARCHLIGHT PHARMA INC
DIN 02045729 · since Jan 6, 2026, no end estimate · Other (Please describe in comments)
Active shortageZESTORETIC
12.5MG
20MG · TABLET · SEARCHLIGHT PHARMA INC
DIN 02045737 · since Jan 6, 2026, no end estimate · Other (Please describe in comments)
Active shortageZESTORETIC
10MG
12.5MG · TABLET · SEARCHLIGHT PHARMA INC
DIN 02103729 · since Sep 2, 2023, no end estimate · Disruption of the manufacture of the drug.
ResolvedTEVA-LISINOPRIL/HCTZ (TYPE Z)
25MG
20MG · TABLET · TEVA CANADA LIMITED
DIN 02301784 · ended Mar 18, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-LISINOPRIL/HCTZ (TYPE Z)
25MG
20MG · TABLET · TEVA CANADA LIMITED
DIN 02301784 · ended Apr 14, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-LISINOPRIL/HCTZ (TYPE Z)
12.5MG
10MG · TABLET · TEVA CANADA LIMITED
DIN 02301768 · ended Mar 25, 2026 · Disruption of the manufacture of the drug.
ResolvedZESTORETIC
12.5MG
20MG · TABLET · SEARCHLIGHT PHARMA INC
DIN 02045737 · ended Jan 6, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-LISINOPRIL/HCTZ (TYPE Z)
20MG
12.5MG · TABLET · TEVA CANADA LIMITED
DIN 02301776 · ended Jan 28, 2026 · Disruption of the manufacture of the drug.
ResolvedZESTORETIC
25MG
20MG · TABLET · SEARCHLIGHT PHARMA INC
DIN 02045729 · ended Jan 7, 2026 · Disruption of the manufacture of the drug.
ResolvedSANDOZ LISINOPRIL HCT
25MG
20MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02302381 · ended Dec 12, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ LISINOPRIL HCT
25MG
20MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02302381 · ended Dec 12, 2025 · Disruption of the manufacture of the drug.
ResolvedSANDOZ LISINOPRIL HCT
12.5MG
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02302365 · ended Sep 26, 2025 · Requirements related to complying with good manufacturing practices.
Showing 12 of 58 reports. All reports are on file with Health Canada.
What's happening
Hydrochlorothiazide Lisinopril is currently affected by 3 active shortage reports filed with Health Canada by SEARCHLIGHT PHARMA INC.
The reported causes are: other (please describe in comments); disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Hydrochlorothiazide Lisinopril is classified under “ACE INHIBITORS, COMBINATIONS” (ATC C09BA).
Recent changes
Common questions
When will Hydrochlorothiazide Lisinopril be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Hydrochlorothiazide Lisinopril in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.